RELX Investor Presentation Deck
STM: We have a unique position in the health ecosystem
We help researchers and healthcare professionals advance science and improve health by facilitating insights and critical decision-making
for customers across the global research and health ecosystems
Medical research
-21% of medical research and -31% share of
total global medical citations over the last five
years¹
☆
Primary research
18% of the global research and 28% share of
total global research citations over the last five
years¹
600,000+ published peer reviewed articles and
>2.5 million article submissions in 2021
18 million unique visitors monthly on
ScienceDirect
1.6 billion+ articles downloaded by
researchers annually
Founding partner of Research4Life, contributing
around 20% of the material
1.2 million articles and 1,600+ journals in
health and life sciences as of March 2022
8 million+ total connections between drugs,
symptoms, biomarkers on our health graph² as
of March 2022
408 million+ downloads on our free Novel
Coronavirus information centre to date
●
Healthcare delivery
94% of US top 100 health systems³, ranked by
bed count, used at least one of our clinical
solutions in 2021
5.5 million images, 84,000 videos and over
1300 clinical overviews included in ClinicalKey
in 2021
7.9 million total patient records4 on Clinical
Path as of March 2022
3 million+ monthly views on ClinicalKey, from
90 countries including 1,900 institutions in the
US
THE LANCET
Cell
ScienceDirect
Scopus
Clinical Key
Source: (1) Based on 2016-2020 market share data (2) Developed by Elsevier, Health Knowledge Graph (H-Graph) (3) Top 100 health systems include US based hospital groups, as defined by Definitive Health database (4) Represent
distinct US patient records through Clinical Path
& RELX
Adapted from Corporate Responsibility teach in on 20 May 2021
57View entire presentation